2024 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2023 CFR > Title 21 > CHAPTER I > SUBCHAPTER D > PART 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2022 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2021 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2020 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2019 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2016 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-threatening Illnesses

2015 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses

2014 CFR > Title 21 > Chapter I > Subchapter D > Part 314 > Subpart H – Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses